Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17960855rdf:typepubmed:Citationlld:pubmed
pubmed-article:17960855lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0014442lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0004238lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C1947933lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0205161lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0683919lld:lifeskim
pubmed-article:17960855lifeskim:mentionsumls-concept:C0205547lld:lifeskim
pubmed-article:17960855pubmed:issue1lld:pubmed
pubmed-article:17960855pubmed:dateCreated2007-12-24lld:pubmed
pubmed-article:17960855pubmed:abstractTextThe prevalence of elevated liver enzymes has not been described in patients with atrial fibrillation (AF) who may be more likely to develop these abnormalities due to comorbidities and medications. As signals of liver injury lead to termination of drug development programs, an attempt to better define the background prevalence would aid in interpreting these elevations in the setting of exposure to a new drug. The aim of this study was to estimate the prevalence and incidence of alanine aminotransferase (ALT) elevations in a cohort with AF.lld:pubmed
pubmed-article:17960855pubmed:languageenglld:pubmed
pubmed-article:17960855pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17960855pubmed:citationSubsetIMlld:pubmed
pubmed-article:17960855pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17960855pubmed:statusMEDLINElld:pubmed
pubmed-article:17960855pubmed:monthJanlld:pubmed
pubmed-article:17960855pubmed:issn1053-8569lld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:StaddonS LSLlld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:KimmelStephen...lld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:YangYu-XiaoYXlld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:BurkeAnneAlld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:WeinerMark...lld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:HanXiaoyanXlld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:MakarGeorge...lld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:NesselLisaLlld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:SellersKimber...lld:pubmed
pubmed-article:17960855pubmed:authorpubmed-author:BennettDimitr...lld:pubmed
pubmed-article:17960855pubmed:issnTypePrintlld:pubmed
pubmed-article:17960855pubmed:volume17lld:pubmed
pubmed-article:17960855pubmed:ownerNLMlld:pubmed
pubmed-article:17960855pubmed:authorsCompleteYlld:pubmed
pubmed-article:17960855pubmed:pagination43-51lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:meshHeadingpubmed-meshheading:17960855...lld:pubmed
pubmed-article:17960855pubmed:year2008lld:pubmed
pubmed-article:17960855pubmed:articleTitleIncidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population.lld:pubmed
pubmed-article:17960855pubmed:affiliationDivision of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. george.makar@uphs.upenn.edulld:pubmed
pubmed-article:17960855pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17960855pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed